The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

With sup­ply short­ages fad­ing and new in­di­ca­tions grow­ing, the main ques­tion for obe­si­ty drug­mak­ers en­ter­ing the new year is what they’ll try and treat next …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER